GENERAL COMMENTS
-Too make sure: BMD was maesured in each study with DXA? THis need to be mentioned within Material and Methode.
-Did all methode had a DEXA within the first week postoperative, or when?
-What about the results of the other Green zones?
-The question is whether the BMD of the Grün zone after short stems can be compared with the one of conventional stems as the areas differ in size.
-Differentiation between short stem of metaphyseal anchorage (partial neck preserving) and shortened standard stems should be discussed.
-In discussion a table or in form of text of non randomised DEXA studies should be added.
Detailed comments:
Page 6, line 20: What means "secondary THA"? Revision THA? Table 1 : add company Introduction I think the statement with respects to revision THA increasing is confusing. In the NJR of England and wales, 3, 5 and 7 year rates have all fallen in recent years. So is it the overall burden of revision that has increased or the proportion of patients having a revision that has increased. Please provide a reference to support this statement. Can you clarify the following "loading, eliminate mismatch of distal stems, and facilitate removal of a well-fixed stem" as I don't think it makes sense.
Methods
Search strategy, It would be useful to indicate what the themes for the search strategy were in the main text, as the thing that underpins your article I do think it should be included in the main text. Inclusion / exclusion Is it really wise to have such a broad range of conditions for inclusion in the study. Fracture neck of femur and OA are very different conditions, pooling of such heterogenous information surely makes generalisability of findings difficult.
Where is the section specifying the primary or secondary outcomes of interest?
Data Extraction How many individuals did the initial screening, and did you plan to asses their agreement. I find the statement with respects to cup revisions being excluded from the calculation of revision as completely inappropriate. Stems and cups interact with one another, and a poor functioning stem may cause the cup to prematurely fail. It is impossible to disentangle the effect of cups on stems and vice versa. All cause revision should be in the analysis. Additionally, patients do not really care if the cup or stem is revised, what they care about is that they have undergone a second procedure.
Statistical analysis. The authors need to describe how SD were obtained from P-values, and what the problems if doing that are if authors do not report exact p-values. Similarly, "We assessed the standard error through t values obtained from P values." Doesn't make sense. Do you mean t-scores? I suggest you have a statistician revise the wording in this section carefully.
Results
It would be useful to report the average followup of all the studies reported.
It is unclear how the one study, with very short followup can be considered with the other studies, that followup in excess of a year. Similarly , the two studies with followup of 9.2 and 11.8 years provide quite different information.
I think it becomes exceptionally difficult to aggregate these 3 studies with rest, as there followup and the mechanisms for failure can be so different.
Discussion
Seems reasonable. My only issue is the section on revision, I do not believe this can be used due to the exclusion of cup revisions.
Conclusions,
Similarly, I think the statements with regards to revision are unreliable.
In addition its not entirely clear if all the studies aggregated together would provide sufficient power to detect a difference in stem failure rates at approximately 2 years. Absence of evidence is not evidence of absence.
Supplemental table 1
You didn't search for THR or THA, A more comprehensive keyword search, coupled with a RCT search filter would have substantially cut down on the number of articles to screen initially.
VERSION 1 -AUTHOR RESPONSE
Responds to the reviewers' comments: Reviewer #1 Comment 1: (I found it very interesting and fine to read. Excellent work! ) Response: Thank you for encouragement. It is our honour to receive your appreciation.
Reviewer #2 Comment 1 (To make sure: BMD was measured in each study with DEXA? This need to be mentioned within Material and Method.) Response: Thank you to the Reviewer for raising a good point. We are very sorry for our incomplete details about BMD measurement. DEXA is useful for evaluating the redistribution of mechanical forces around the hip joint following implantation and is considered the most reliable tool with which to evaluate bone remodelling after THA using different stem designs. We only included studies that measured BMD with DEXA. According to the Reviewer's suggestion, we have rewritten this section on p. 7, lines 6-7: "The primary outcome measurements evaluated in our meta-analysis included BMD changes in different femoral zones to assess the efficacy of short stems by evaluating whether they can achieve better bone remodelling, postoperatively measured by dual energy X-ray absorptiometry (DEXA), and the revision rate to evaluate the safety of short-stem prostheses."
Comment 2: (Did all method had a DEXA within the first week postoperative, or when? What about the results of the other Gruen zones?)
Response: Thank you for your helpful reminder. We are very sorry for our incomplete details about the time points of BMD measurement and our negligence in omitting the results in other Gruen zones from the included studies. Although meta-analysis was not successfully performed because insufficient data were available to evaluate the results of other Gruen zones, as BMD changes were one of the primary outcomes of our review, we should make a general description of the results of all Gruen zones. Therefore, according to the Reviewer's suggestion, we have rewritten this section on p. 13, lines 20-21 and p. 14-15,: "Five studies had a DEXA scan within the first week after surgery [19] [20] [21] [22] 31] . Sluimer et al. [19] reported that DEXA scans were conducted at 4 to 7 days, 7 weeks, and 3, 6, 12, and 24 months postoperatively, and all femoral prosthetic zones were measured. The results showed that the BMD around both femoral components decreased immediately after surgery in all Gruen zones. After 2 years, this decrease was followed by an increase to 94% to 100% of the original BMD, except in Gruen zones 1 (G1) and 7. Freitag et al. [22] reported that the BMD data were collected at 1 week and 3 and 12 months after surgery, including all zones. The result showed that upon evaluation at 1 year, the BMD was lower than at the 7-day postoperative assessment for both implants in all zones, aside from zone 3 in the short-stem group, which showed a small increase. In addition, there was a significant difference in BMD changes at 1 year between the groups in G1 and Gruen zone 6 (G6). The periprosthetic decrease in the BMD was most pronounced in Gruen zone 7 (G7) for both implants. Salemyr et al. reported that DEXA scans were taken at 1 and 2 days and 3, 6, 12 and 24 months postoperatively, with reported BMD values in G1 and G7. Additionally, they reported the BMD changes of Gruen zones 1-7 together as an entity and found 5% lower bone resorption in the ultra-short relative to the conventional group. Kim et al. [24] reported that DEXA scans were taken at 1 week, 1 year, 10 years and at the final follow-up after surgery. BMD values were available in G1 and G7. Koyano et al.[21] only measured BMD values at the final follow-up, and the result showed that BMD values in zone 2, 3, and 6 on the anatomic-stem side were significantly lower than those on the straight-stem side. DEXA scans were taken within 3 days after surgery and 1 and 2 years postoperatively. Schilcher et al. [31] reported the BMD values of G1, G5 and G7, and their results showed no significant difference between the two groups at 1 year and 2 years after surgery. However, G5 was created by the authors within G1, which was different from the original description of the zones. Kim et al.[23] reported the BMD values of G1 and G7, and the first DEXA scan was taken 1 week after surgery, with further scans obtained at the final follow-up (3 years postoperatively).
The results indicated that in the short-stem group, the BMD at 3 years after surgery was significantly increased in zone 1 but slightly decreased in zone 7, and the BMD at 3 years after surgery was significantly decreased in zones 1 and 7."
Comment 3: (The question is whether the BMD of the Gruen zone after short stems can be compared with the one of conventional stems as the areas differ in size.) Response: Thank you for your comment. The definition of Gruen zones was first described to investigate the survival rate after total hip arthroplasty. According to Gruen's description, the proximal femur was delineated into 7 zones-the proximal-lateral zone (zone 1), the proximal-medial zone (zone 7), the medial midstem region (zone 6), the lateral midstem region (zone 2), the stem tip (zone 4), the distal-lateral zone (zone 3), and the distal-medial zone (zone 5)-for the detailed evaluation and classification of the loosening of femoral components. However, the studies included different types of stems. Therefore, these zones were divided based on different stem lengths and sizes. Moreover, studies included in our review measured changes in the BMD value mainly in Gruen zones 1 and 7, which can better assess proximal femoral remodelling around the implant and achieve proximal load transfer. In addition, as reported in some studies, analysis of the seven periprosthetic Gruen zones is the most commonly used protocol to evaluate bone remodelling after implantation of conventional femoral stems and is easily adapted to the short-stem design. Moreover, some adjustments of the zones were made by the authors of our included studies. Salemyr et al. analysed zones 1-2 and 6-7 in the ultra-short-stem group, which were compared to zones 1 and 7, respectively, in the conventional-stem group. Kim et al. considered the region from the lower border of the lesser trochanter to the tip of the greater trochanter as zone 1 in both groups, and the region from the lower border of the lesser trochanter to the femoral neck-cut level was defined as zone 7, definitions which aimed to make the proximal zones in both stems anatomically comparable and easily reproducible. Therefore, despite differences in the sizes of Gruen zones between the short-and conventional-stem occur, we considered the BMD values comparable.
Comment 4: (Differentiation between short stem of metaphyseal anchorage (partial neck preserving) and shortened standard stems should be discussed) Response: Thank you for your helpful suggestions. Considering the Reviewer's comment, we have added a discussion of the differentiation between short stems with metaphyseal anchorage (partial neck preserving) and shortened standard stems in the discussion in our revised manuscript. The specific contents are as follows: "However, as no clear definition of short stem exists, there are different classification systems for short stems. Gulow et al.
[35] divided short stems into 3 types according to the different anchoring principles, including (1) resurfacing endoprostheses anchoring on the epiphysis; (2) collum endoprostheses solely anchoring on the metaphysis; and (3) short collumpreserving stems anchoring on the metaphysis with short anchorage on the diaphysis. Oldenrijk et al.
[36] classified short stems into 3 categories: (1) "collum": conical or cylindrical ultra-short stems, with complete anchorage in the femoral neck; (2) "partial collum": partial femoral neck-sparing curved designs; and (3) "trochanter-sparing": trochanter-sparing but not neck-sparing, with a shortened tapered stem. The differentiation of short stems within a single classification system was clear. However, there was little difference between the short stem of the metaphyseal anchorage (partial neck preserving) group and shortened standard stems according to the classification principles mentioned above. According to the classification system of Khanuja et al. [37] , which categorized SS into four categories based on fixation principles and the location of proximal loading, metaphyseal anchorage short stems were those retaining the femoral neck by using partial collum short stems, with a curved or angulated distal end of the stem contacting the proximal lateral cortex and potentially improving biomechanical reconstruction. Shortened standard stems were similar to conventional, proximally porous-coated tapered designs with a shorter length or a reduced distal end of the stem, which were designed for proximal stress transfer. This type of stem is rarely neck-preserving and often extends to the upper diaphysis. With their tapered-wedge design and proximal porous coating, these stems achieve fixation proximally [38] ."
Comment 5: (In discussion a table or in form of text of non randomised DEXA studies should be added.) Response: Thank you to the Reviewer for raising a good point. We tried to summarize the current RCTs on short-stem total hip arthroplasty, and the present results derived from all available comparative data are the first to document the differences in postoperative bone remodelling. However, the majority of evidence on this topic is non-randomized. Considering the Reviewer's suggestion, we have added a discussion of non-randomized DEXA in the text (p. 22, lines 13-21， and p. 23, lines 1-14). The specific contents are as follows: "Some non-randomized studies have evaluated BMD changes with DEXA. Lerch et al.
[49] examined BMD changes following Metha short stem implantation, and the result showed that compared with baseline values measured immediately postoperatively, there was about a 10% periprosthetic bone loss in G7 after 1 year, which was consistent with the result of another study performed by Jahnke et al. [26] . However, Lerch et al.
reported that a regain of BMD in the G7 was found 2 years post-surgery. Chen et al.
[50] performed a retrospective BMD analysis following implantation of the Mayo short stem and indicated that compared to the contralateral hip, the decrease (14.4-17.9 %) of the BMD was significant in G1, 6 and 7 and was much less affected in other zones. Lazarinis et al.
[51] carried out a prospective cohort study of collum femoris-preserving (CFP) stems, and DEXA after 1 year showed a substantial loss of the BMD of between 13-31% in Gruen zones 7, 6, and 2. Nevertheless, some research has indicted contradicting results. A prospective study evaluated the periprosthetic BMD change of the Fitmore stem and Trabecular Metal Primary stem, and a lower periprosthetic bone loss was observed in all Gruen zones [52] . Moreover, a retrospective study of within 10-year follow-ups found no significant difference in the periprosthetic BMD between short anatomical stems and metaphyseal anchored short stems. The bone mineral density significantly increased in zone 1 at each follow-up but slightly decreased in zone 7 in both groups. However, the results of these studies were insufficient to provide a power of comparability, as they were non-randomized or lacked a direct comparison between short and conventional stems."
Comment 6: (Detailed comments: Page 6, line 20: What means "secondary THA"? Revision THA? Response: Thank you. We are very sorry for our careless mistakes. We have corrected the following mistake based on your suggestion: the word "secondary" was corrected to "revision".
Comment 7: (Table 1 : add company; Page 11; line 49/50: I recommend to write the heading like BMD, HHS, MTPM out) Response: Thank you for your helpful suggestion. According to the Reviewer's suggestion, details of the companies were added to Table 1 . In addition, we have written out the headings and marked them in red in the revised paper.
Reviewer #3 Comment 1: (The authors' definition of short stem hips is somewhat unclear. For instance, the Omnifit HA stems are included. It is unclear to me, why this stem is considered a short stem, other than proximal coating.) Response: Thank you for your reminder. We are so sorry we provided an unclear definition of short stem. We have added text to the introduction according to the Reviewer's comment on p. 4, lines 5-8. Our reasons for including the Omnifit HA stems in our review are listed as follows: First, as described by Sluimer et al., the Omnifit HA stem was designed to further facilitate load transmission in the proximal region of the femur and prevent distal fixation, with a stem that is 2.5 cm shorter than regular stems. The Omnifit HA uses normalization of the proximal, medial, and lateral aspects and has a polished finish on the noncoated distal part. However, as no precise definition of short stem exist, there are different classification systems of short stems. Khanuja et al. categorized short stems based on fixation principles and the location of proximal loading, and we concluded that the Omnifit HA stem was more in line with the description of a shortened tapered conventional stem, as a shortened conventional design with primary fixation in the proximal femoral metaphysis and proximal coating of the stem. To some extent, Omnifit HA can also be classified as a trochanter-sparing stem as described by Oldenrijk et al. Secondly, stems with surface modifications such as proximal hydroxyapatite and porous coatings are commonly used for primary cementless THA to accelerate proximal osseointegration and maintain proximal load transfer. However, Miyatake K et al. compared 2 anatomical stems with the same geometric configurations and constructed of different materials and coatings and suggested that there was no apparent difference in bone mineral density between the two stems. Finally, the main difference between the two Omnifit HA stems was the length of the stem.
In the absence of a clear definition of "short", these stems may be on the borderline of being short. Based on the above points, we considered the Omnifit HA 1070 stem a short stem.
Comment 2: (Considering the differences between short stem, one can not generalize the outcome of BMD studies of different stems to short stems in general. I would advise to at least group the stems in different stem types and preferably assess each stem individually.) Response: We appreciate for your professional suggestion. Considering the Reviewer's comment, we added a discussion of the BMD changes of different types of short stems. The specific contents are as follows: "According to Oldenrijk et al., most of the short stems included in our review were trochanter-sparing stems [19, 20, 23, 24, [30] [31] [32] . One was classified as a collum stem, and another one as a partial collum stem. However, BMD values were available only for the trochanter-sparing stems included in our review. We tried to individually assess each short stem of the 7 studies which reported the BMD values of different zones. Three studies evaluated the BMD changes of the Proxima stem (DePuy), and the others reported on Fitmore (Zimmer), Omnifit-HA1090 (Osteonics), Super Secur-Fit(Stryker), and Taperloc Microplasty (Biomet). However, limited data and variance of follow-up did not allow for further assessments."
Comment 3: (Safety and efficacy should be specified. Define main / primary outcome parameter and secondary outcome parameters. This article seems to focus primarily on BMD changes / bone remodelling post short stem THA. Lower level of evidence, with numerous non-randomized BMD studies is however ignored. These studies should somehow be incorporated as well, since the majority of evidence on this topic is non-randomized.) Response: Thank you to the Reviewer for raising a good point. We are so sorry for not specifying safety and efficacy in our study. We rewrote the following section on p. 9, lines 10-14: "The primary outcome measurements evaluated in our meta-analysis included BMD changes in different femoral zones to assess the efficacy of short stems by evaluating whether they can achieve better bone remodelling, postoperatively measured by dual energy X-ray absorptiometry (DEXA), and the revision rate to evaluate the safety of short-stem prostheses. The secondary outcomes were as follows: the Harris Hip Score to evaluate the functional outcome; the presence of radiolucent lines, which suggests loosening of the prosthesis; and the maximum total point motion (MTPM) to evaluate stem migration in the 3 axial directions." Comment 4: (Lower level of evidence, with numerous non-randomized BMD studies is however ignored. These studies should somehow be incorporated as well, since the majority of evidence on this topic is non-randomized.) Response: Thank you to the Reviewer for providing a constructive suggestion. We are so sorry for our negligence in not incorporating non-randomized BMD studies. Considering the Reviewer's suggestion and to draw objective conclusions from this body of research, a discussion of some non-randomized BMD studies was incorporated and added into this systematic review (p. 22, lines 13-21，and p. 23, lines 1-14.
Comment 5: (Page 5. superior survival rates and clinical outcomes....this studies main focus is BMD remodeling.) Response: Thank you for your reminder. We are very sorry for our errors. The main focus of this review is to assess the efficacy of bone remodelling with short stems and examine the revision rate to evaluate the associated safety. Therefore, based on your suggestion, we have rewritten that section as follows: "bone remodelling" was added.
Comment 6: (Please check the grammar: page 7. line 22, and page 12. line 34,) Response: We are grateful for the Reviewer's comment. We have made the following changes: on p. 8, line 1-2, "Where actual P values obtained from t-tests are quoted, the corresponding t value may be obtained from a table of the t distributions", and on p. 16, line 5, the word "were" was added.
Comment 7: (Discussion: please start with a brief summary of primary findings, the initial part of the discussion is a repetition of the introduction.) Response: We appreciate the Reviewer's helpful suggestions. According to the Reviewer's suggestion, we added a brief summary of the primary findings in this systematic review on p. 18, line 12-15: "This meta-analysis of 12 RCTs including 1130 patients and comparing the efficacy and safety of SS and CS showed more proximal bone loss in G7 in the CS group but no significant difference in zone 1 within 2 years postsurgery. We found no significant differences in the revision rate, HHS, MTPM and radiolucent lines." In addition, on p. 14, lines 29-45, "Conventional stem... been reported" was deleted.
Comment 8: (please provide a description of the strengths and limitations. The current section on page 20 line 204... does not suffice.)
Response: Thank you for your valuable suggestions to improve the quality of our manuscript. We agree with the Reviewer's suggestion that a description of the strengths and limitations is not sufficient. After careful review, we rewrote the relevant section; on p. 20, line 37, "strength and" was added, and on p. 21, lines 19-24, the text was revised to read "Moreover, based on the limited data, we only evaluated bone remodelling of trochanter-sparing SS, while other categories were not assessed and require future study. Finally, although reasons for revision plans were measured in included studies, details of the failures were not known. We only evaluated the revision rates for any reason, without subgroup analysis of the different mechanisms, and we cannot make any statements regarding patient satisfaction."
Comment 9: (Please provide a PRISMA checklist and flowchart for this systematic review) Response: We thank the Reviewer for the helpful suggestions. We have provided the PRISMA checklist (p. 29-30) and flowchart (p. 30) of the relevant study selection process in the manuscript. However, the locations were changed in the revised manuscript. The PRISMA checklist is presented on research checklist, and the flowchart is presented on Fig. 1 Reviewer #4 Comment 1: (Abstract: The following sentence should be more neutral "Compared with conventional stem prostheses (CS), short stem prostheses (SS) may achieve superior preservation of proximal bone stock and stability." i.e. bone stock preservation and stability is not known.) Response: Thank you for your reminder. We are very sorry for our errors. Whether SS can achieve superior bone stock preservation and stability compared to CS is what this systematic review was conducted to investigate, and we corrected the following statements to be more neutral: on p. 2, line 3, "Compared with conventional stem prostheses (CS)" was deleted; on line 3, "was designed to" was added; and on lines 2, "compared with conventional-stem prostheses (CS)" was added.
Comment 2: (It would be useful to define the primary outcome of interest for the review. I can see BMD, and risk of revision are reported, but a more explicit statement would be useful. When writing the conclusion, the authors would do well to remember "absence of evidence is not evidence of absence") Response: We thank the Reviewer for the helpful suggestions. It is useful and important to explicitly define the primary outcome of interest. According to the Reviewer's suggestion, we have rewritten the statement "investigate the safety and efficacy of SS" as "determine the proximal bone remodelling, revision rate, Harris Hip Score, radiolucent line and maximum total point motion (MTPM) values of both SS and CS". The conclusion of this review that SS may provide superior bone remodelling was based on the result of periprosthetic BMD change analysis, which showed less BMD changes in Gruen zone 7 at 1 year and 2 years postoperatively in the SS group and no significant difference in zone 1. Only two different timepoints of periprosthetic BMD changes from baseline were compared; however, previous studies showed that maximum bone remodelling takes place at six months after surgery and reaches a plateau after approximately one year. Additional biomechanical adaptation to the implant occurs slowly during the following one to two years until a BMD plateau stage is reached. Therefore, this review analysed data obtained from the most active period of periprosthetic bone remodelling. In addition, BMD changes in other zones were not available to compare in this review, which is important for reflecting bone remodelling more precisely. Gruen zones 1 and 7, which are located in the calcar region of the femur, were considered the regions with greatest clinical importance and have been widely used to assess proximal loading after THA and to further investigate bone remodelling after surgery. Moreover, many factors influence the course of BMD around implanted THA stems, including patient sex, age, weight, BMI and bone mass and stem design. There is disagreement about the factors that potentially influence periprosthetic bone remodelling. However, according to current research, there seems to be a consensus concerning the belief that stem design and fixation remain the major aspects influencing periprosthetic bone remodelling.
Therefore, despite the absence of other Gruen zones and additional potential factors, we insist that our conclusion was objective.
Comment 3: (Strengths and limitations. It would be useful to briefly mention the range of follow up here as you mention it.) Response: Thank you to the Reviewer for raising a good point. We are very sorry for providing incomplete details about the range of follow ups. According to the Reviewer's suggestion, we have rewritten the following sections: on p. 3, lines 6, "of 3.9 years (range, 0.115-11.8 years)" was added, and on p. 27, line 11, "(range, 0.115-11.8 years)" was added.
Comment 4: (Introduction. I think the statement with respects to revision THA increasing is confusing.
In the NJR of England and wales, 3, 5 and 7 year rates have all fallen in recent years. So is it the overall burden of revision that has increased or the proportion of patients having a revision that has increased. Please provide a reference to support this statement) Response: Thank you for your valuable suggestions to improve the quality of our manuscript. We are very sorry for our confusing statement and error. Young patients have been considered at higher risk for revision due to their higher activity level relative to elderly patients. The demand for primary THA among patients younger than 65 years was projected to exceed 50% of TJR recipients by 2011 and 2016. THA has been indicated in relatively young patients, who have a higher rate of revision surgeries than elderly patients. A recent study identified all THA revisions in the Nationwide Inpatient Sample from 2007 to 2013 in America. The study concluded that the THA revision rate has significantly increased in patients between 45 and 64 years of age. However, the revision rate in other countries is not known. Therefore, considering the Reviewer's suggestion, we have rewritten the following part: on p. 3, line 10-12, "revision THAs have increased, particularly in patients who are young and thus have the potential for revision" was deleted and "the overall burden of revision has increased[2], particularly in patients who are young and thus have the potential for revision, and the THA revision rate has significantly increased in patients between 45 and 64 years of age in the United States[3]" was added. References were also added.
Comment 5: (Can you clarify the following "loading, eliminate mismatch of distal stems, and facilitate removal of a well-fixed stem" as I don't think it makes sense.) Response: Thank you for your reminder. We are very sorry for our incorrect statement. We wanted to clarify what SS was designed to achieve. However, we mistakenly incorporated some subjective ideas, which had not been proven. Therefore, we have rewritten the following section: on p. 4, lines 12-13 "eliminate mismatch of distal stems, and facilitate removal of a well-fixed stem" was deleted.
Comment 6: (Methods. Search strategy, It would be useful to indicate what the themes for the search strategy were in the main text, as the thing that underpins your article I do think it should be included in the main text.) Response: Special thanks to you for your professional comments. We have rewritten the following section: on p. 5 line 11-12, "using the following keywords and their combinations: short stem, conventional stem, arthroplasty, hip, randomized controlled trial" was added.
Comment 7: (Inclusion / exclusion. Is it really wise to have such a broad range of conditions for inclusion in the study. Fracture neck of femur and OA are very different conditions, pooling of such heterogenous information surely makes generalisability of findings difficult. Where is the section specifying the primary or secondary outcomes of interest?) Response: Thank you very much for the professional advice. The conditions of the patients included in this review included femoral neck fracture, osteoarthritis and osteonecrosis of the femoral head. We tried to assess short-stem protheses for patients with different conditions, which is helpful in providing a more accurate and objective conclusion. The conditions of the patients were measured in the studies. However, the results were not analysed or discussed separately. Therefore, we were not able to further investigate SS for patients with different conditions. Moreover, a cohort study recently published showed that in the case of idiopathic AVN, the use of femoral neck-preserving implants has produced no significant differences in aseptic osteonecrosis and other indications. Despite the heterogenous exit and although the differences between conditions for THA remained unclear, we pooled the available data to roughly describe SS for THA. We hope more studies that investigate SS relative to different conditions are published in the future to guide our work. As the outcome of interest, according to the Reviewer's suggestion, we have written a section specifying the primary or secondary outcomes of interest, and the section "outcome measurements" was added (p. 7, lines 4-9).
Comment 8: (Data Extraction. How many individuals did the initial screening, and did you plan to assess their agreement.) Response: Thank you for your reminder. We are so sorry for our incomplete details about our search strategies. We have rewritten the following sections: on p. 5, lines 9-10, "Two reviewers independently searched the electronic databases" was added, and on p. 6, lines 11-12, "resolved through discussion" was deleted and "discussed by two reviewers and resolved by consensus through discussion with other reviewers" was added.
Comment 9:(I find the statement with respects to cup revisions being excluded from the calculation of revision as completely inappropriate. Stems and cups interact with one another, and a poor functioning stem may cause the cup to prematurely fail. It is impossible to disentangle the effect of cups on stems and vice versa. All causes revision should be in the analysis.) Response: Special thanks for the professional advice. We calculated revisions based on the number of revisions due to periprosthetic fracture or loosening, which is a method commonly used to assess revision rates in other studies. However, as the Reviewer commented, the stems and cups interact with one another, and disentangling the effect of cups on stems is unreasonable. In addition, patients' main concern is a second procedure. Therefore, considering the Reviewers' suggestion, we have revised the calculation for revision: on p. 7, line 4, "periprosthetic fracture or loosening" was changed to "all causes," and on p. 6, lines 13, "Cup revisions alone were not included in the calculation" was deleted. We made changes in the manuscript accordingly. Here, we did not list the changes, but they are marked in red in the revised paper. We assessed the standard error through t values obtained from P values. For data are reported as medians and interquartile ranges; we assumed that the median was equivalent to the mean and that the width of the interquartile range was equivalent to 1.35 times the SD" was deleted, and "An assumption that the standard deviations (SDs) of the outcome measurements were the same in both groups was required in all cases, and the standard deviation would then be used for both intervention groups. Where actual P values obtained from ttests are quoted, the corresponding t value may be obtained from a table of the t distributions. The degrees of freedom are given by NE + NC -2, where NE and NC are the sample sizes in the experimental and control groups, respectively. The t value is the ratio of the difference in means to the standard error of the difference in means. The standard error of the difference in means can therefore be obtained by dividing the difference in means (MD) by the t value: SE=MD/t. The within-group standard deviation can be obtained from the standard error of the difference in means using the following formula: SD=SE/√((1/NE)+(1/NC)). If authors do not report exact p-values but a 95% confidence interval is available for the difference in means, then the same standard error can be calculated as SE=(upper limit -lower limit)/3.92, as long as the trial is large. For 90% confidence intervals, 3.92 should be replaced by 3.29, and for 99% confidence intervals, it should be replaced by 5.15. If the sample size is small, then confidence intervals should have been calculated using a t distribution. The numbers 3.92, 3.29 and 5.15 need to be replaced with larger numbers specific to both the t distribution and the sample size and can be obtained from tables of the t distribution with degrees of freedom equal to NE + NC -2, where NE and NC are the sample sizes in the two groups, respectively. Relevant details of the t distribution are available as appendices of many statistical textbooks or by using standard computer spreadsheet packages" was added.
Comment 11: (Results. It would be useful to report the average followup of all the studies reported.) Response: Thank you for your helpful suggestion. The average follow-up time of all studies was 3.9 years, and this information was added to the revised manuscript.
Comment 12: (It is unclear how the one study, with very short followup can be considered with the other studies, that followup in excess of a year. Similarly, the two studies with followup of 9.2 and 11.8 years provide quite different information. I think it becomes exceptionally difficult to aggregate these 3 studies with rest, as there followup and the mechanisms for failure can be so different.) Response: Special thanks for your professional comments. As reported by The New Zealand joint registry Eighteen Year report and other studies, the main reasons for primary THA include dislocation, loosening acetabulum, loosening femur, deep infection, pain. Revision with short follow-up often occurred within 1 year postoperatively for reasons including dislocation, infection and prosthetic fracture. This list was different from the causes at the midterm follow-up (range, 1-10 years), at which point loosening and pain were the main causes of revision. Since we had a special interest in "revision for all causes," we did not particularly focus on different revision causes. Most of the included studies provided information about the reasons for revisions or the protocol for revision, but the data were not precise enough for adequate subgroup analysis. However, combining the studies with short-and long-term follow-ups may have led to biased results in terms of higher revision rates. Therefore, considering the suggestion of the reviewer and reports from previous studies, we divided the studies into three groups (<2 years, 2-8 years and >8 years) based on the timepoint at which revision occurred, and revision rates were analysed separately. Results of the analysis showed no significant differences regarding the revision rate results in any subgroup (<2 years: RR=1.56; 95%CI, 0.46, 5.35; P=0.58, [2] [3] [4] [5] [6] [7] [8] 95%CI, 0.40, 3.67; P=0.95) or in total (RR=1.52; 95%CI, 0.71, 3.26; P=0.94).
Comment 13: (Discussion. Seems reasonable. My only issue is the section on revision, I do not believe this can be used due to the exclusion of cup revisions. Conclusions. Similarly, I think the statements with regards to revision are unreliable.) Response: Thank you for your positive comments and valuable suggestion. We have corrected the calculation of the revision rate and extracted data on all causes of revision in the section on data extraction and quality assessment in the revised manuscript.
Comment 14: (It is not entirely clear if all the studies aggregated together would provide sufficient power to detect a difference in stem failure rates at approximately 2 years. Absence of evidence is not evidence of absence.) Response: Thank you for your professional comments. We aggregated studies with different follow-up times, and the results showed no significant difference between SS and CS, though sufficient power may not have been provided to detect the difference. However, subgroup analysis without two studies with follow-ups at 9.2 and 11.8 years suggested a consistent result. Therefore, according to the current limited evidence, we insist that the result of this review can provide sufficient power to detect a difference in stem failure rates at approximately 2 years.
